爱尔眼科：公司屈光手术客单价持续企稳回升

Core Viewpoint - The ophthalmology industry has experienced a price war in refractive surgery over the past couple of years, but the situation is expected to improve starting from Q3 2024 due to brand reputation and advancements in surgical techniques [1] Company Summary - Aier Eye Hospital (300015) indicated that the average transaction price for refractive surgeries is stabilizing and expected to rise continuously from Q3 2024 onwards, benefiting from its brand reputation and the iterative upgrade of surgical methods [1]